Papers: 10.1371/journal.pone.0233089

https://doi.org/10.1371/journal.pone.0233089

Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor

Cited by: 18
Author(s): Melissa F. Adasme, Daniele Parisi, Kristien Van Belle, Sebastian Salentin, V. Joachim Haupt, Gary Jennings, Jörg‐Christian Heinrich, Jean Herman, Ben Sprangers, Thierry Louat, Yves Moreau, Michael Schroeder
Published: about 5 years ago

Software Mentions 1